Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
British Journal of Clinical Pharmacology|November 27, 2008
Inhibition of flucloxacillin tubular renal secretion by piperacillinCornelia B Landersdorfer, Carl M J Kirkpatrick, Martina Kinzig, et al.
Journal of Clinical Pharmacology|May 16, 2009
Lack of pharmacokinetic drug interactions following concomitant administration of telavancin with aztreonam or piperacillin/tazobactam in healthy participantsShekman L Wong, Fritz Sörgel, Martina Kinzig, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2003
Concentrations in plasma, urinary excretion, and bactericidal activity of linezolid (600 milligrams) versus those of ciprofloxacin (500 milligrams) in healthy volunteers receiving a single oral doseFlorian M E Wagenlehner, Stephan Wydra, Hajime Onda, et al.
Pharmacology|July 9, 2018
Quantification of Hydrochlorothiazide and Ramipril/Ramiprilate in Blood Serum and Cerebrospinal Fluid: A Pharmacokinetic Assessment of Central Nervous System Adverse EffectsAli Sigaroudi, Martina Kinzig, Oliver Wahl, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2009
Bone penetration of amoxicillin and clavulanic acid evaluated by population pharmacokinetics and Monte Carlo simulationCornelia B Landersdorfer, Martina Kinzig, Jürgen B Bulitta, et al.
Clinical Pharmacology and Therapeutics|February 2, 2002
Effects of grapefruit juice on the pharmacokinetics of sildenafilAlexander Jetter, Martina Kinzig-Schippers, Monika Walchner-Bonjean, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 27, 2024
A high performance liquid chromatography-tandem mass spectrometry assay for therapeutic drug monitoring of 10 drug compounds commonly used for antimicrobial therapy in plasma and serum of critically ill patients: Method optimization, validation, cross-validation and clinical applicationSylvia K Neef, Anna-Diana Hinderer, Wassim Arbash, et al.
International Journal of Antimicrobial Agents|December 14, 2005
Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral doseFlorian M E Wagenlehner, Martina Kinzig-Schippers, Uwe Tischmeyer, et al.
European Journal of Clinical Pharmacology|March 28, 2024
Understanding adefovir pharmacokinetics as a component of a transporter phenotyping cocktailQian Dong, Chunli Chen, Max Taubert, et al.
Antimicrobial Agents and Chemotherapy|July 11, 2007
Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trialSamir G Sakka, Anna K Glauner, Jürgen B Bulitta, et al.
Pageof 9